Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.044 AUD Market Closed
Updated: May 17, 2024

Prescient Therapeutics Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prescient Therapeutics Ltd
Interest Income Expense Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Prescient Therapeutics Ltd
ASX:PTX
Interest Income Expense
-AU$18.7k
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Interest Income Expense
AU$2.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
Mesoblast Ltd
ASX:MSB
Interest Income Expense
-$18.4m
CAGR 3-Years
-7%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Interest Income Expense
-$469m
CAGR 3-Years
-38%
CAGR 5-Years
-27%
CAGR 10-Years
-25%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Interest Income Expense
-AU$3.5m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
-40%
Telix Pharmaceuticals Ltd
ASX:TLX
Interest Income Expense
-AU$733k
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Prescient Therapeutics Ltd's Interest Income Expense?
Interest Income Expense
-18.7k AUD

Based on the financial report for Dec 31, 2023, Prescient Therapeutics Ltd's Interest Income Expense amounts to -18.7k AUD.

What is Prescient Therapeutics Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-55%

The average annual Interest Income Expense growth rates for Prescient Therapeutics Ltd have been -55% over the past three years .